CRISAFULLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 519
EU - Europa 260
AS - Asia 116
AF - Africa 6
AN - Antartide 1
SA - Sud America 1
Totale 903
Nazione #
US - Stati Uniti d'America 518
IT - Italia 88
HK - Hong Kong 48
FI - Finlandia 37
CN - Cina 31
DE - Germania 30
SG - Singapore 29
UA - Ucraina 28
IE - Irlanda 22
GB - Regno Unito 14
FR - Francia 8
SE - Svezia 8
MK - Macedonia 7
EG - Egitto 4
CZ - Repubblica Ceca 3
GR - Grecia 3
PL - Polonia 3
CH - Svizzera 2
ES - Italia 2
IN - India 2
PH - Filippine 2
TR - Turchia 2
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CA - Canada 1
CI - Costa d'Avorio 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IQ - Iraq 1
JP - Giappone 1
NL - Olanda 1
PT - Portogallo 1
RO - Romania 1
UG - Uganda 1
Totale 903
Città #
Fairfield 82
Hong Kong 48
Ashburn 44
Chandler 41
New York 36
Helsinki 35
Houston 35
Princeton 34
Seattle 30
Wilmington 29
Woodbridge 26
Cambridge 24
Dublin 22
Jacksonville 22
Shanghai 16
Singapore 16
Brescia 15
Ann Arbor 14
Los Angeles 10
Rome 8
San Diego 7
Crotone 5
Des Moines 5
Munich 5
Alexandria 4
Bosio 4
London 4
Bergamo 3
Brno 3
Castelli Calepio 3
Duncan 3
Jinan 3
Nanjing 3
Polska 3
Shenyang 3
Skopje 3
Strasbourg 3
Barrafranca 2
Beijing 2
Cosenza 2
Forlì 2
Lappeenranta 2
Manerbio 2
Milan 2
Motta Baluffi 2
Palermo 2
Redwood City 2
San Giovanni la Punta 2
Santa Cruz de Tenerife 2
Treviso 2
Turin 2
Vittoria 2
Abidjan 1
Amsterdam 1
Atlanta 1
Augusta 1
Cagayan de Oro 1
Changsha 1
Charlotte 1
Falkenstein 1
Guimarães 1
Hyderabad 1
Islington 1
Jiaxing 1
Kilburn 1
Kocaeli 1
Magdeburg 1
Mountain View 1
Mumbai 1
Nanchang 1
New Bedfont 1
Sedriano 1
Soncino 1
Spreitenbach 1
Tianjin 1
Tokyo 1
Toronto 1
Tower Hamlets 1
Walnut 1
Wandsworth 1
Washington 1
Watford 1
Totale 711
Nome #
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 102
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study 86
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 73
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 70
Pregnancy and reproductive aspects of systemic lupus erythematosus 65
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 54
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 53
Does seronegative obstetric APS exist? “pro” and “cons” 48
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 48
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study 42
Impact of COVID-19 on outpatient therapy with iloprost for systemic sclerosis digital ulcers 39
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 30
Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. 30
Managing puerperium in patients with systemic autoimmune diseases: an update 30
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study) 22
Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes 21
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 18
SALUTE RIPRODUTTIVA NELLE PAZIENTI CON MALATTIE REUMATOLOGICHE SEGUITE PROSPETTICAMENTE DA TEAM MULTIDISCIPLINARI: ANALISI DELL’OUTCOME MATERNO-FETALE, VALUTAZIONE DELLA TERAPIA IN GRAVIDANZA E IDENTIFICAZIONE DI FATTORI DI RISCHIO PER EVENTI AVVERSI 16
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 15
Retention rate of IL-1 inhibitors in Schnitzler's syndrome 15
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 12
Women of childbearing age living with spondyloarthritis: time for improving knowledge and counselling about reproductive issues 12
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 11
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 9
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 7
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 3
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 2
Totale 933
Categoria #
all - tutte 8.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 1 2 9 5 6 7 6 4 8 1 2
2020/2021264 1 21 18 52 8 32 19 17 19 41 19 17
2021/2022167 14 23 12 7 5 13 6 8 10 20 16 33
2022/2023138 22 7 2 2 14 39 5 10 23 1 7 6
2023/2024269 19 2 23 15 7 45 13 17 52 22 12 42
2024/202524 15 9 0 0 0 0 0 0 0 0 0 0
Totale 933